RESUMO
OBJECTIVE: To explore the effect of a balanced model for early psychological crisis intervention on anxiety and depression in caregivers of the elderly. METHODS: A convenience sampling method was used to select 234 caregivers for the elderly as the study subjects. A random number table method was used to divide them into a control group(116) and an intervention group(118). The control group was given conventional psychological crisis intervention; the intervention group received a balanced model for early psychological crisis intervention on the basis of conventional psychological crisis intervention. The anxiety and depression scores of the two groups were investigated before and after the intervention using the Anxiety Self-Rating Scale and Depression Self-Rating Scale, respectively. RESULTS: The anxiety scores of the control group were(43.0±6.8) and(40.1±6.3), and the depression scores were(45.4±12.0) and(42.7±11.4), before and after the intervention, respectively. The pre-and post-intervention scores were(43.5±6.5) and(38.4±5.6) for anxiety and(46.9±6.0) and(39.8±5.6) for depression in the intervention group, respectively. Before the intervention, the anxiety and depression scores of the 2 groups were compared separately, and the difference was not statistically significant(all P>0.05). In the control group, only the anxiety score was lower than the pre-intervention score(P<0.01); in the intervention group, both the post-anxiety and post-depression scores were lower than the pre-intervention scores(all P<0.01). After the intervention, the anxiety and depression scores of the caregivers in the intervention group were lower than those of the control group, respectively(all P<0.05). CONCLUSION: The balanced model for early psychological crisis intervention can effectively alleviate anxiety and depression in caregivers of the elderly.
RESUMO
<p><b>OBJECTIVE</b>To study the feasibility of chemoprevention of esophageal adenocarcinoma by celecoxib, a selective cyclooxygenase-2(COX-2) inhibitor using a rat model.</p><p><b>METHODS</b>Rats were divided into 3 groups: model group, celecoxib group, and control group. The rat surgical model was established by performing a gastrojejunostomy plus an esophagojejunostomy 5 mm distal to the gastrojejunal anastomosis. Twenty-eight weeks after surgery, all the animals were sacrificed and the pathological changes in the esophagus were examined macroscopically. COX-2 expression was analyzed by immunohistochemistry. Prostaglandin E2(PGE2) level was measured by enzyme-linked immunosorbent assay(ELISA).</p><p><b>RESULTS</b>The incidence of Barrett's esophagus and esophageal adenocarcinoma in the model group was 84% and 57% respectively, significantly higher than those in the control group(P<0.01). The incidence of esophageal adenocarcinoma in the celecoxib-treated group was significantly lower than that in the model group(P<0.01), and no esophageal adenocarcinoma was detected in the control group. COX-2 expression was detected in 100% of reflux esophagitis, Barrett esophagus and esophageal adenocarcinoma, but not found in the normal tissue from the esophagus and the jejunum(P<0.01). The PGE2 level in the esophageal tissue in the model group was significantly higher than that in the control group(P<0.01). Rats in the celecoxib-treated group had significantly lower PGE2 level than that in the model group(P<0.01). The PGE2 levels were significantly higher in rats with cancer than those without cancer(P<0.01).</p><p><b>CONCLUSION</b>Celecoxib successfully prevents the development of esophageal adenocarcinoma in a rat surgical model with mixed reflux of acid and duodenal juice and significantly decreases the risk of Barrett esophagus developing esophageal adenocarcinoma. COX-2 maybe an effective selective target of chemoprevention for esophageal adenocarcinoma.</p>